https://de.wikipedia.org/w/api.php?action=feedcontributions&feedformat=atom&user=CirclesAndTrianglesWikipedia - Benutzerbeiträge [de]2025-05-01T10:42:14ZBenutzerbeiträgeMediaWiki 1.44.0-wmf.25https://de.wikipedia.org/w/index.php?title=Benutzer_Diskussion:CirclesAndTriangles&diff=230952741Benutzer Diskussion:CirclesAndTriangles2023-02-16T14:42:11Z<p>CirclesAndTriangles: /* Trials24 GmBH */</p>
<hr />
<div>..</div>CirclesAndTriangleshttps://de.wikipedia.org/w/index.php?title=Benutzer_Diskussion:CirclesAndTriangles&diff=230952666Benutzer Diskussion:CirclesAndTriangles2023-02-16T14:39:40Z<p>CirclesAndTriangles: Neuer Abschnitt /* Trials24 GmBH */</p>
<hr />
<div>== Trials24 GmBH ==<br />
<br />
Trials24 is a fully remote Company founded by Dr. Tobias Kruse in August 2017 which specializes in accelerating digital patient recruitment for clinical trials. In 2011, Dr. Kruse encountered challenges recruiting patients while developing a vaccine against Helicobacter pylori for his Ph.D. An analysis of the recruitment process revealed that 30% of trials must be terminated due to outdated methods, and up to 80% of trials have difficulties meeting their enrolment goals1. The idea was born to launch a digital campaign for the recruitment of H. pylori-positive patients. This campaign was so successful that the enrolment could close one month ahead of time. As a passionate scientist, this experience prompted Dr. Kruse to create the service provider he would have wished for by founding Trials24 in August 2017. In the past years, Trials24 has expanded internationally and is now successfully recruiting patients in multiple countries worldwide. --[[Benutzer:CirclesAndTriangles|CirclesAndTriangles]] ([[Benutzer Diskussion:CirclesAndTriangles|Diskussion]]) 15:39, 16. Feb. 2023 (CET)</div>CirclesAndTriangles